Malaysia: Malaysia and Japan have taken another step forward in advancing biotechnology innovation through a proposed research collaboration between BioNexus Status company, Glyken Bio Products Sdn. Bhd. (Glyken) and Japan's Ortho Group to explore the application of Glyken's proprietary bird's nest extracts in therapeutic medicine and healthcare development.

According to BERNAMA News Agency, facilitated by the Malaysian Bioeconomy Development Corporation (Bioeconomy Corporation), the collaboration aims to establish a platform for joint research, clinical studies, and healthcare innovation by leveraging the expertise of both parties to develop therapeutic and wellness solutions to support healthy longevity.